Alvotech ALVO 深 沪
等待开盘 10-08 09:30:00 美东时间
5.85
-0.290
-4.72%
华盛通- 最 高6.14
- 今 开6.10
- 成交量 86.46万股
- 最 低 5.845
- 昨 收 6.14
- 总市值 20.87亿
- 52周最高 8.745
- 市盈率 静 61.06
- 换手率 0.24%
- 52周最低 2.94
- 委 比 60.35%
- 总股本 3.57亿
- 历史最高 18.00
- 量 比 0.60
- 振 幅 4.80%
- 历史最低 2.94
- 每 手 1
- 风险率 1.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alvotech taps LOTTE Biologics to support growing biosimilar portfolio
Alvotech (ALVO) announced on Tuesday that it agreed to a long-term deal with LOTTE Biologics to manufacture multiple biosimilar drugs at its Syracuse, New York facility. The deal adds 40K liters of ma...
10-07 04:53
Alvotech Gets FDA Nod For Added US Manufacturing Capacity For Humira Biosimilar SIMLANDI, Doubling Drug Substance Capacity At Reykjavik Site
Approval enables AVT02 drug substance for U.S. commercial supply to be manufactured in either of Alvotech’s two Reykjavik drug substance suites Further confirms resolution of FDA inspection-related matters at the Reykjavik site
10-05 16:21
FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®
Alvotech announced FDA approval of a supplement to the BLA for AVT02 (adalimumab-ryvk), allowing production of the drug substance in a second suite at its Reykjavik facility. This doubles manufacturing capacity for U.S. supply and confirms resolution of FDA inspection-related matters. The approval enhances flexibility and capacity for AVT02 production, supporting commercial supply to the U.S. market. The FDA's July 2026 inspection closure with a ...
10-05 08:00
美股大行评级 | 矿业股获齐声唱多！金田、纽曼矿业等目标价均获上调；携程遭看淡至60美元，较现价仍溢价5成
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从10.25美元升至11美元；Needham：上调Rocket Pharmaceuticals"买入"评级，目标价9美元
09-17 16:16
This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst Scott Berg upgraded Similarweb Ltd (NYSE:SMWB) from Hold to Buy and announced a p...
09-16 20:54
Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8
Barclays analyst Glen Santangelo upgrades Alvotech (NASDAQ:ALVO) from Underweight to Overweight and raises the price target from $4 to $8.
09-16 20:47
Alvotech’s Entyvio Biosimilar Push Advances as FDA Accepts AVT80 BLA
The latest announcement is out from Alvotech ( ($ALVO) ). On August 31, 2026, A...
08-31 20:27
美股牛股 | AI基建股SUPX狂飙24%！ALVO获美银力挺飙近19%；加密货币概念股CYPH、ZCSH双双暴升逾18%
AI基建股SUPX狂飙24%；业绩指引超预期！ALVO获美银力挺飙近19%；加密货币概念股CYPH、ZCSH双双升逾18%>>
08-25 17:38
美股大行评级 | 首予买入！Jersey Mike's获13家大行评级；大摩、富国银行齐上调迈威尔科技目标价，最高升至310美元
今日重点评级关注：Truist Securities：维持CoreWeave"买入"评级，目标价从155美元升至165美元；百德：维持亚德诺"跑赢大市"评级，目标价从450美元升至675美元
08-25 11:47
B of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7
B of A Securities analyst Jason Gerberry initiates coverage on Alvotech (NASDAQ:ALVO) with a Buy rating and announces Price Target of $7.
08-24 19:59
